Patient expectations did not predict outcome of drug and behavioral treatment of urgency urinary incontinence

Mary P. FitzGerald, Catherine E. DuBeau, Stephen R. Kraus, Harry W. Johnson, David D. Rahn, Veronica Mallett, Anne M. Stoddard, Halina M. Zyczynski

Research output: Contribution to journalArticle

Abstract

Objectives: This study aimed to determine whether expectations of treatment outcomes in women participating in a drug and behavioral treatment trial for urge urinary incontinence are related to patient factors, demographics, health-related locus of control, and treatment outcomes. Methods: Baseline assessments included expectations (improvement in bladder condition, time to improvement in bladder condition, and duration of improvement) and theMedical Health Locus of Control (MHLC) scale. Outcomes were measured by the Patient Global Impression of Improvement scale (PGI-I) at the end of active treatment (10 weeks) and 8 months after trial start. Results: At baseline among 173 subjects, 114 (66%) believed their incontinence would get "very much better," 94 (55%) expected improvement by 1 month, and 111 (66%) expected improvement would last for the rest of their lives. There were no significant associations between baseline expectations or MHLC with the Patient Global Impression of Improvement scale at 10 weeks or 8 months. Conclusions: Expectations of treatment outcome and MHLC did not predict eventual patient-reported treatment outcome in this sample of women with urge-predominant urinary incontinence participating in a trial of drug and behavioral therapy.

Original languageEnglish (US)
Pages (from-to)231-237
Number of pages7
JournalFemale Pelvic Medicine and Reconstructive Surgery
Volume17
Issue number5
DOIs
StatePublished - 2011

Fingerprint

Urinary Incontinence
Urge Urinary Incontinence
Internal-External Control
Pharmaceutical Preparations
Urinary Bladder
Health
Therapeutics
Demography
Drug Therapy

Keywords

  • Patient expectations
  • Urinary incontinence
  • Urinary urgency incontinence

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Surgery
  • Urology

Cite this

Patient expectations did not predict outcome of drug and behavioral treatment of urgency urinary incontinence. / FitzGerald, Mary P.; DuBeau, Catherine E.; Kraus, Stephen R.; Johnson, Harry W.; Rahn, David D.; Mallett, Veronica; Stoddard, Anne M.; Zyczynski, Halina M.

In: Female Pelvic Medicine and Reconstructive Surgery, Vol. 17, No. 5, 2011, p. 231-237.

Research output: Contribution to journalArticle

FitzGerald, Mary P. ; DuBeau, Catherine E. ; Kraus, Stephen R. ; Johnson, Harry W. ; Rahn, David D. ; Mallett, Veronica ; Stoddard, Anne M. ; Zyczynski, Halina M. / Patient expectations did not predict outcome of drug and behavioral treatment of urgency urinary incontinence. In: Female Pelvic Medicine and Reconstructive Surgery. 2011 ; Vol. 17, No. 5. pp. 231-237.
@article{75c358f3c7854814ab16fbd9196d8ff9,
title = "Patient expectations did not predict outcome of drug and behavioral treatment of urgency urinary incontinence",
abstract = "Objectives: This study aimed to determine whether expectations of treatment outcomes in women participating in a drug and behavioral treatment trial for urge urinary incontinence are related to patient factors, demographics, health-related locus of control, and treatment outcomes. Methods: Baseline assessments included expectations (improvement in bladder condition, time to improvement in bladder condition, and duration of improvement) and theMedical Health Locus of Control (MHLC) scale. Outcomes were measured by the Patient Global Impression of Improvement scale (PGI-I) at the end of active treatment (10 weeks) and 8 months after trial start. Results: At baseline among 173 subjects, 114 (66{\%}) believed their incontinence would get {"}very much better,{"} 94 (55{\%}) expected improvement by 1 month, and 111 (66{\%}) expected improvement would last for the rest of their lives. There were no significant associations between baseline expectations or MHLC with the Patient Global Impression of Improvement scale at 10 weeks or 8 months. Conclusions: Expectations of treatment outcome and MHLC did not predict eventual patient-reported treatment outcome in this sample of women with urge-predominant urinary incontinence participating in a trial of drug and behavioral therapy.",
keywords = "Patient expectations, Urinary incontinence, Urinary urgency incontinence",
author = "FitzGerald, {Mary P.} and DuBeau, {Catherine E.} and Kraus, {Stephen R.} and Johnson, {Harry W.} and Rahn, {David D.} and Veronica Mallett and Stoddard, {Anne M.} and Zyczynski, {Halina M.}",
year = "2011",
doi = "10.1097/SPV.0b013e31822dd10b",
language = "English (US)",
volume = "17",
pages = "231--237",
journal = "Female Pelvic Medicine and Reconstructive Surgery",
issn = "2151-8378",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Patient expectations did not predict outcome of drug and behavioral treatment of urgency urinary incontinence

AU - FitzGerald, Mary P.

AU - DuBeau, Catherine E.

AU - Kraus, Stephen R.

AU - Johnson, Harry W.

AU - Rahn, David D.

AU - Mallett, Veronica

AU - Stoddard, Anne M.

AU - Zyczynski, Halina M.

PY - 2011

Y1 - 2011

N2 - Objectives: This study aimed to determine whether expectations of treatment outcomes in women participating in a drug and behavioral treatment trial for urge urinary incontinence are related to patient factors, demographics, health-related locus of control, and treatment outcomes. Methods: Baseline assessments included expectations (improvement in bladder condition, time to improvement in bladder condition, and duration of improvement) and theMedical Health Locus of Control (MHLC) scale. Outcomes were measured by the Patient Global Impression of Improvement scale (PGI-I) at the end of active treatment (10 weeks) and 8 months after trial start. Results: At baseline among 173 subjects, 114 (66%) believed their incontinence would get "very much better," 94 (55%) expected improvement by 1 month, and 111 (66%) expected improvement would last for the rest of their lives. There were no significant associations between baseline expectations or MHLC with the Patient Global Impression of Improvement scale at 10 weeks or 8 months. Conclusions: Expectations of treatment outcome and MHLC did not predict eventual patient-reported treatment outcome in this sample of women with urge-predominant urinary incontinence participating in a trial of drug and behavioral therapy.

AB - Objectives: This study aimed to determine whether expectations of treatment outcomes in women participating in a drug and behavioral treatment trial for urge urinary incontinence are related to patient factors, demographics, health-related locus of control, and treatment outcomes. Methods: Baseline assessments included expectations (improvement in bladder condition, time to improvement in bladder condition, and duration of improvement) and theMedical Health Locus of Control (MHLC) scale. Outcomes were measured by the Patient Global Impression of Improvement scale (PGI-I) at the end of active treatment (10 weeks) and 8 months after trial start. Results: At baseline among 173 subjects, 114 (66%) believed their incontinence would get "very much better," 94 (55%) expected improvement by 1 month, and 111 (66%) expected improvement would last for the rest of their lives. There were no significant associations between baseline expectations or MHLC with the Patient Global Impression of Improvement scale at 10 weeks or 8 months. Conclusions: Expectations of treatment outcome and MHLC did not predict eventual patient-reported treatment outcome in this sample of women with urge-predominant urinary incontinence participating in a trial of drug and behavioral therapy.

KW - Patient expectations

KW - Urinary incontinence

KW - Urinary urgency incontinence

UR - http://www.scopus.com/inward/record.url?scp=80053030405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053030405&partnerID=8YFLogxK

U2 - 10.1097/SPV.0b013e31822dd10b

DO - 10.1097/SPV.0b013e31822dd10b

M3 - Article

VL - 17

SP - 231

EP - 237

JO - Female Pelvic Medicine and Reconstructive Surgery

JF - Female Pelvic Medicine and Reconstructive Surgery

SN - 2151-8378

IS - 5

ER -